Clinical Trials Browser

Resistant Solid Malignancies × liposomal doxorubicin × Clear all

NCT00703170 2013-05-24

Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies

Phase 1 Completed

Resistant Solid Malignancies